Вогнищеве ураження міокарда лівого шлуночка і ризик раптової смерті при саркоїдозі серця 

Н.Д. Орищин , Ю.А. Іванів , Н.В. Лозинська , О.Я. Сорока , С.С. Павлик , Ю.О. Паламарчук , М.С. Сороківський 

Література

1. Aizer A., Stern E.H., Gomes J.A. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis // Am. J. Cardiol.– 2005.– Vol. 96.– P. 276–282.
2. Cheong B.Y., Muthupillai R., Nemeth M. et al. The utility of delayed-enhancement magnetic resonance imaging for identifing non-ischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis // Vasc. Diffuse Lung Dis.– 2009 – Vol. 26.– P. 39–46.
3. Epstein A.E., DiMarco J.P., Ellenbogen K.A. et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. // J. Am. Coll. Cardiol.– 2008.– Vol. 51.– P. e1–62.
4. Evanchan J.P., Crouser E.D., Kalbfleisch S.J. Cardiac Sarcoidosis: Recent Advances in Diagnosis and Treatment and an Argument for the Need for a Systematic Multidisciplinary Approach to Management // J. Inn. Cardiac Rhythm Management.– 2013.– Vol. 4.– P. 1160–1174.
5. Hiraga H., Yuwai K., Hiroe M. et al. Guideline for diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary diseases from the Japanese Ministry of Health and Welfare // Japanese Ministry of Health and Welfare.– 1993.– Р. 23–24.
6. Kato Y., Morimoto S., Uemura A. et al. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block // Sarcoidosis Vasc. Diffuse Lung Dis.– 2003.– Vol. 20.– P.133–137.
7. Mehta D., Lubitz S.A., Frankel Z et al. Cardiac involvement in patients with sarcoidosis // Chest.– 2008.– Vol. 133.– P. 1426–1435.
8. Mehta D., Mori N., Goldbarg S.H. et al. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: clinical perspective // Circ. Arrhythm. Electrophysiol.– 2011.– Vol. 4.– P. 43–48.
9. Patel M.R., Cawley P.J., Heitner J.F. et al. Detection of myocardial damage in patients with sarcoidosis // Circulation.– 2009.– Vol. 120.– P. 1969–1977.
10. Roberts W.C., McAllister H.A., Ferrans V.J. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11) // Am. J. Med.– 1977.– Vol. 63.– P. 86–108.
11. Smedema J.P., Snoep G., van Kroonenburgh M.P. et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis // J. Am. Coll. Cardiol.– 2005.– Vol. 45.– P. 1683–1690.
12. Soejima K., Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities // J. Cardiovasc. Electrophysiol.– 2009.– Vol. 20.– P. 578–583.
13. Tadamura E., Yamamuro M., Kubo S. et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging // Am. J. Roentgenol.– 2005.– Vol. 185.– P. 110–115.
14. Youssef G., Beanlands R.S., Birnie D.H. et al. Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment // Heart.– 2011.– Vol. 97.– P. 2078–2087.
15. Yodogawa K., Seino Y., Ohara T. et al. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis // Ann. Noninvasive Electrocardiol.– 2011.– Vol. 16.– P. 140–147.